DCF — ADVENTHEALTH CONNERTON
Enterprise Value: $-76.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-76.0M
Enterprise Value
$-23.9M
PV of Cash Flows
$-52.0M
PV of Terminal Value
$-83.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $45.0M | $-4.8M | -11.0% | $-6.7M | $-6.1M |
| Year 2 | $46.3M | $-4.5M | -10.0% | $-6.4M | $-5.3M |
| Year 3 | $47.7M | $-4.1M | -9.0% | $-6.1M | $-4.6M |
| Year 4 | $49.1M | $-4.0M | -8.0% | $-6.1M | $-4.1M |
| Year 5 | $50.6M | $-4.0M | -8.0% | $-6.1M | $-3.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-76.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$43.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11129516012279286
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5